← Open Payments lookup

VEDAVANI TIRUVEEDHULA: Open Payments

NPI 1760865497 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$675 in 34 payments from 9 companies in 2025. Trend: 2023 $1,171 · 2024 $913 · 2025 $675

Food & beverage: $564Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.8$232
ABBVIE INC.9$135
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$89
Alkermes, Inc.3$53
Vanda Pharmaceuticals Inc.3$51
Neurocrine BioSciences, Inc.2$47
Otsuka America Pharmaceutical, Inc.2$35
Axsome Therapeutics, Inc.1$18
ACADIA Pharmaceuticals Inc1$16

Products named: VRAYLAR, AUSTEDO XR, CAPLYTA, ARISTADA, FANAPT, INGREZZA, Auvelity, ABILIFY MAINTENA.

Industry payments across MA — which companies pay providers there.